Camurus’ Oczyesa receives European marketing authorization for treatment of acromegaly: Lund, Sweden Wednesday, July 2, 2025, 17:00 Hrs [IST] Camurus, an international, science- ...

Indian pharmaceutical market saw a late surge in June, with growth during the quarter primarily driven by cardiac, respiratory, CNS, and anti-diabetic therapies, said Emkay Global analysts.

Camurus, an international, science-led biopharmaceutical company, announced that the European Commission (EC) has granted Oczyesa, octreotide subcutaneous depot, marketing authorization for the ...

Mumbai doctors Dr Sheetal Goyal, consultant neurologist at Wockhardt Hospitals in Mumbai Central, treated her for the tumour ...

Living with medical conditions is often difficult and may often go unnoticed in many cases as people believe it is not so ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

Acromegaly is a rare, serious, and chronic disease characterized by excessive growth of bone and tissue, resulting in enlarged hands, feet, facial features, and inner organs.

Facial recognition technology, originally developed for border crossings, has been expanded to help drive mass deportation efforts.

Two years later, he received a historic face and double hand transplant at age 22. His donor was 47 years old Immediately after the accident, Joe was in a three-month coma.

UK-based celebrity nutritionist Rose Ferguson previously revealed an uptick in the her clients who are worried about facial changes from these medications.